Syndax Pharmaceuticals (NASDAQ:SNDX) is scheduled to announce Q2 earnings results on Monday, August 4th, after market close.

PROS Holdings grew subscription revenue 12% in Q2, well ahead of management’s guidance range. Click here to find out why PRO ...

Capstone Copper Corp.'s strong execution at Mantoverde and growth projects like Santo Domingo signal long-term value. Click ...

Amazon's stock sank on Thursday afternoon, weighed down by mixed guidance and AI competition, though the company beat Q2 ...

Q2 2025 Management View CEO Jude I. Bricker emphasized the company's unique, diversified business model, noting "our diverse ...

Data from Square shows that the average tip on food and beverage transactions has dipped, though drink purchases at bars ...

Installations expected to reach 40,000 homes across North America; company advances toward cash flow positivity in 2025 ...

Regeneron topped Wall Street estimates for second-quarter results on Friday, on robust demand for its blockbuster eczema drug ...

Exxon Mobil’s profit dropped in the second quarter to the lowest level in four years as oil prices declined amid an increase ...

Trump Media & Technology Group, the parent company of Truth Social that is majority-owned by President Donald Trump, posted ...

While the company booked a $3.2 billion pre-tax windfall from its investment in NuScale Power’s small modular reactor (SMR) ...

Key Points GAAP revenue for Q2 2025 was $88.6 million, coming in about $1.3 million below analyst consensus. Adjusted EBITDA margin improved to 32%, up from 27% in Q2 2024. Glo Fiber Expansion Markets ...